Despite the EphA3-related molecular alterations associated with IL-26 alone, treatment with IL-26 alone did not alter TNBC growth; rather, the effect of IL-26 on TNBC tumor growth was seen in the setting of EGFR-TKI exposure with an increased ER stress response. Here, IL26 is linked to neoplasm.